Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,208 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Enrolling by Invitation

Harvesting Cells for Experimental Cancer Treatments

NCT00068003

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +31 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by Invitation

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

NCT05600933

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +34 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by Invitation

CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma

NCT06605833

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +19 more
Locations: The Royal Marsden NHS Foundation Trust London, United Kingdom

View Trial Details

Enrolling by Invitation

Melphalan Chemoreduction for Ocular Melanoma

NCT05893654

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations: Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP Ribeirão Preto, São Paulo, Brazil

View Trial Details

Enrolling by Invitation

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

NCT05212103

Conditions: Acute Myeloid Leukemia, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations: Turku University Hospital, Turku PET Centre Turku, Finland

View Trial Details

Not Yet Recruiting

Clinical Genetics Branch Eligibility Screening Survey

NCT07005297

Conditions: Abnormalities, Multiple, Anemia, Anemia, Aplastic, +44 more
Locations: National Cancer Institute Rockville, Maryland, United States

View Trial Details

Not Yet Recruiting

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

NCT07574047

Conditions: Advanced Melanoma, Melanoma, Neoplasms, +10 more
Locations: HFR Fribourg Fribourg, Canton of Fribourg, Switzerland

Ente Ospedaliero Cantonale (EOC) Bellinzona, Switzerland

Inselspital, Bern Bern, Switzerland

Hôpitaux Universitaires de Genève HUG Geneva, Switzerland

View Trial Details

Not Yet Recruiting

A Comparative Usability Study of Two Total Body Skin Imaging Systems

NCT07740642

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: University Hospital Basel Basel, Canton of Basel-City, Switzerland

View Trial Details

Not Yet Recruiting

A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

NCT07689812

Conditions: Adenocarcinoma, Advanced Solid Tumors, Advanced Solid Tumors Cancer, +54 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events

NCT07694414

Conditions: Immune-Related Adverse Events, Melanoma, Neoplasms, +10 more
Locations: National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital Herlev, Denmark

View Trial Details

Melanoma

Melanoma trial results

Related conditions